172 related articles for article (PubMed ID: 27987319)
1. Unusual scrotal and penile ulcerations together with palmar-plantar erythrodysesthesia syndrome in a patient with metastatic colon carcinoma treated with capecitabine.
Ljubojevic Hadzavdic S; Stulhofer Buzina D; Murtezani I; Skerlev M
J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):e304-e306. PubMed ID: 27987319
[No Abstract] [Full Text] [Related]
2. Palmar-plantar erythrodysesthesia associated with capecitabine chemotherapy: a case report.
Kigen G; Busakhala N; Njiru E; Chite F; Loehrer P
Pan Afr Med J; 2015; 21():228. PubMed ID: 26523170
[TBL] [Abstract][Full Text] [Related]
3. Unilateral Capecitabine-related Hand-foot Syndrome.
Matsuda S; Koketsu H; Hayakawa M; Nagata N
Intern Med; 2015; 54(21):2779. PubMed ID: 26521911
[No Abstract] [Full Text] [Related]
4. Capecitabine-induced lichenoid drug eruption: a case report.
Gehlhausen JR; Strausburg MB; Aouthmany M; Katona TM; Turner MJ
Dermatol Online J; 2017 Feb; 23(2):. PubMed ID: 28329488
[TBL] [Abstract][Full Text] [Related]
5. Palmar-plantar erythrodysesthesia associated with scrotal and penile involvement with capecitabine.
Sapp CM; DeSimone P
Clin Colorectal Cancer; 2007 Jan; 6(5):382-5. PubMed ID: 17311704
[TBL] [Abstract][Full Text] [Related]
6. Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer.
Suto T; Ishiguro M; Hamada C; Kunieda K; Masuko H; Kondo K; Ishida H; Nishimura G; Sasaki K; Morita T; Hazama S; Maeda K; Mishima H; Ike H; Sadahiro S; Sugihara K; Okajima M; Saji S; Sakamoto J; Tomita N
Int J Clin Oncol; 2017 Jun; 22(3):494-504. PubMed ID: 28078540
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine safety profile, innovative and generic adjuvant formulation of nonmetastatic colorectal cancer.
Sánchez-Gundín J; Torres-Suárez AI; Fernández-Carballido AM; Barreda-Hernández D
Farm Hosp; 2019 Sep; 43(5):158-162. PubMed ID: 31469628
[TBL] [Abstract][Full Text] [Related]
8. The concurrence of subacute cutaneous lupus erythematosus and hand-foot syndrome in a patient undergoing capecitabine chemotherapy.
Li Z; Jiang N; Xu Y
Australas J Dermatol; 2016 Feb; 57(1):e14-6. PubMed ID: 25495707
[TBL] [Abstract][Full Text] [Related]
9. Genital fixed drug eruption: cross-reactivity between doxycycline and minocycline.
Correia O; Delgado L; Polónia J
Clin Exp Dermatol; 1999 Mar; 24(2):137. PubMed ID: 10447381
[No Abstract] [Full Text] [Related]
10. Possible Pathways of Capecitabine-Induced Hand-Foot Syndrome.
Lou Y; Wang Q; Zheng J; Hu H; Liu L; Hong D; Zeng S
Chem Res Toxicol; 2016 Oct; 29(10):1591-1601. PubMed ID: 27631426
[TBL] [Abstract][Full Text] [Related]
11. "Hand-foot" syndrome-an unusual case of plantar pathology presenting to a burns unit.
Goutos I; Kaniorou-Larai M; Dziewulski P
J Burn Care Res; 2009; 30(3):529-32. PubMed ID: 19349881
[TBL] [Abstract][Full Text] [Related]
12. A pilot randomized double-blind, placebo-controlled study on the effects of the topical application of pyridoxine on palmar-plantar erythrodysesthesia (PPE) induced by capecitabine or pegylated liposomal doxorubicin (PLD).
Charalambous A; Tsitsi T; Astras G; Paikousis L; Filippou E
Eur J Oncol Nurs; 2021 Feb; 50():101866. PubMed ID: 33227569
[TBL] [Abstract][Full Text] [Related]
13. Capecitabine-Related Eruption Mimicking Dermatomyositis in 2 Patients With Metastatic Breast Cancer.
Cobos GA; Nelson CA; Alsarheed A; LaChance A; Laga AC; LeBoeuf N; Vleugels RA
JAMA Dermatol; 2020 Jan; 156(1):103-104. PubMed ID: 31693064
[No Abstract] [Full Text] [Related]
14. [Genital ulcer associated to an allergic reaction due to intravesical instillation of mitomycin].
Crespillo Romeo FA; Sánchez Cuervo M; Bermejo Vicedo T
Farm Hosp; 2013; 37(3):263-4. PubMed ID: 23789803
[No Abstract] [Full Text] [Related]
15. Better compliance with the guidelines on hand-foot syndrome in patients treated with capecitabine in colorectal and breast cancer as a result of nursing education.
Krzemieniecki K; Zygulska AL; Kucharz J; Stokłosa
Przegl Lek; 2016; 73(7):460-4. PubMed ID: 29676887
[TBL] [Abstract][Full Text] [Related]
16. Eruptive nevi in a patient with metastatic breast cancer.
Calleja-Algarra A; Aragón-Miguel R; Velasco-Tamariz V; Andrés-Lencina JJ; Prieto Barrios M; Maroñas Jiménez L; Ortiz Romero PL; Monsálvez Honrubia V
Int J Dermatol; 2017 Dec; 56(12):1508-1509. PubMed ID: 28960262
[No Abstract] [Full Text] [Related]
17. Successful Capecitabine Desensitization for a Delayed-Type Hypersensitivity Reaction.
Demir S; Olgac M; Saglam S; Gelincik A; Colakoglu B; Buyukozturk S
J Investig Allergol Clin Immunol; 2016; 26(1):66-7. PubMed ID: 27012024
[No Abstract] [Full Text] [Related]
18. Capecitabine and Hand-foot Syndrome: A Case Report.
Uppala PK; Varghese AM; Yella SST; Velmurugan H; Thangaraju P; Krishna Sasanka KSBS
Infect Disord Drug Targets; 2023; 23(1):e140622205973. PubMed ID: 35708076
[TBL] [Abstract][Full Text] [Related]
19. [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].
Risum S; Langer SW
Ugeskr Laeger; 2003 Aug; 165(33):3161-2. PubMed ID: 12968412
[TBL] [Abstract][Full Text] [Related]
20. Multiple inflammatory lesions in an oncology patient.
Pigem R; Maroñas-Jiménez L; Pau-Charles I; Mascaró JM
Int J Dermatol; 2016 Dec; 55(12):1301-1303. PubMed ID: 26710313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
